Bruner JM - Search Results

1

Gamma-radiation sensitivity and risk of glioma.

Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. Bondy ML, et al. Among authors: bruner jm. J Natl Cancer Inst. 2001 Oct 17;93(20):1553-7. doi: 10.1093/jnci/93.20.1553. J Natl Cancer Inst. 2001. PMID: 11604478

2

Mutagen sensitivity and risk of gliomas: a case-control analysis.

Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q. Bondy ML, et al. Among authors: bruner jm. Cancer Res. 1996 Apr 1;56(7):1484-6. Cancer Res. 1996. PMID: 8603389

3

Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q. El-Zein R, et al. Among authors: bruner jm. Carcinogenesis. 1999 May;20(5):811-5. doi: 10.1093/carcin/20.5.811. Carcinogenesis. 1999. PMID: 10334198

4

Risk assessment for developing gliomas: a comparison of two cytogenetic approaches.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q. El-Zein R, et al. Among authors: bruner jm. Mutat Res. 2001 Jan 25;490(1):35-44. doi: 10.1016/s1383-5718(00)00154-6. Mutat Res. 2001. PMID: 11152970

5

Correlation of p53 immunoreactivity and sequencing in patients with glioma.

Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: bruner jm. Mol Carcinog. 1996 Jan;15(1):1-4. doi: 10.1002/(SICI)1098-2744(199601)15:1<1::AID-MC1>3.0.CO;2-O. Mol Carcinog. 1996. PMID: 8561860

6

Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.

Wei Q, Bondy ML, Mao L, Gaun Y, Cheng L, Cunningham J, Fan Y, Bruner JM, Yung WK, Levin VA, Kyritsis AP. Wei Q, et al. Among authors: bruner jm. Cancer Res. 1997 May 1;57(9):1673-7. Cancer Res. 1997. PMID: 9135006

7

Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.

Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML. Trizna Z, et al. Among authors: bruner jm. Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):553-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9641501

8

Prognostic significance of p53 immunoreactivity in patients with glioma.

Kyritsis AP, Bondy ML, Hess KR, Cunningham JE, Zhu D, Amos CJ, Yung WK, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: bruner jm. Clin Cancer Res. 1995 Dec;1(12):1617-22. Clin Cancer Res. 1995. PMID: 9815964

9

Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells.

Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA, Kyritsis AP. Fueyo J, et al. Oncogene. 1996 Jan 4;12(1):103-10. Oncogene. 1996. PMID: 8552379

10

Mutations of the p16 gene in gliomas.

Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA, Bruner J. Kyritsis AP, et al. Oncogene. 1996 Jan 4;12(1):63-7. Oncogene. 1996. PMID: 8552400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page